Kalera
KALRQ · OTC
About KALRQ
- Employees
- 438
- Headquarters
- Orlando, Florida
- Listed
- Jun 30, 2022
- Sector
- Consumer Staples
- Industry
- Food Products
- Website
- kalera.com
KALRQ key statistics
- Market cap
- 1
- Price-earnings ratio
- 0.00
- Dividend yield
- —
- Average volume
- 150
- Volume
- 1
- Open price
- $0.00
- High today
- $0.00
- Low today
- $0.00
- 52 Week high
- $0.0002
- 52 Week low
- $0.00
Kalera (KALRQ) at a glance
Kalera (KALRQ) last traded at $0.00, with a market cap of 1 and a price-to-earnings ratio of 0.00.
Volume so far is 1 shares, below the average of 150 shares a day.
Over the past year Kalera has ranged from $0.00 to $0.0002, and now sits 0% of the way up that range.
Similar companies
Companies in the same industry as Kalera
Most active stocks
Highest trading volume today
- SDSTStardust Power$0.02−23.66%
- SHFSSHF Holdings$0.0899−4.36%
- WFFWF Holding$0.0929−3.83%
- RCTRedCloud Holdings$0.084+1.94%
- KORUDirexion Shares ETF Trust$11.34−4.87%
- RBNERobin Energy$0.3978−23.65%
- DKIDarkiris$0.0479−6.08%
- SOXLDirexion Shares ETF Trust$97.55−1.12%
- SOXSDirexion Shares ETF Trust$47.13+1.07%
- WHLRWheeler Real Estate Investment Trust$0.3597+2.19%
- NWGLCL Workshop Group$0.1522+27.90%
- SPCXSpace Exploration Technologies$147.79−0.11%
Newly listed
Companies that went public in the past six weeks
- TCXBTCGX Acquisition Corp. II$10.56+1.54%
- CTYCITY THERAPEUTICS$20.83−2.94%
- IAMIambic Therapeutics$16.01−2.02%
- AMROAmaero$5.68+1.25%
- FLSCFrazier Life Sciences Acquisition Corp. II$10.28−0.10%
- TRXBTRex Bio$14.44−2.43%
- RTSNRetension Pharmaceuticals$16.18−0.92%
- PAXGUPine Tree Acquisition$9.98+0.00%
- PORTUSouthport Acquisition Corp. IIListed Oct 1, 2026
- CHWMChilwa Minerals$5.18+3.39%
- ACCVAccelevation Holdings$12.31−1.44%
- RZAIROZE AI$10.28+1.28%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.